PI-LAB-2026-185

Orforglipron, Independent Lab Report

Orforglipron 24mg · Meridian Health Direct

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 98.1% met the stated ≥98% claim. Content measured 101.4% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
98.1%

Label claimed ≥98%

Content accuracy
101.4%

24.33mg measured against 24mg claimed

Test recency
Current cycle

Published 8 months ago

Specimen PI-LAB-2026-185 Tested by Axiom Mass Spec Services 8 samples tested from this company Purity & Testing score 97/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 98.1% Meets claim
Identity (MS) Orforglipron Confirmed Matches label
Content 24 mg 24.33 mg Within 5% of label

Methodology & chain of custody

LC-MS/MS identity confirmation with quantitative amino acid analysis.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Axiom Mass Spec Services. See our full testing methodology.

Lot / batch
D2918-26
Purchased
Analysed
Published
Laboratory
Axiom Mass Spec Services
Test type
Purity, identity & content

Original laboratory report: PI-LAB-2026-185-report.pdf (document delivery arrives with the production storage backend)

More Tests, Meridian Health Direct

Semaglutide (Oral)
Purity 97.5% Verified
Cagrilintide
Purity 97.0% Verified
Cagrilintide
Purity 94.1% Verified

More Tests, Orforglipron

Orforglipron Cardinal Metabolic Clinic
Purity 98.6% Verified
Orforglipron Verity Research Chemicals
Purity 98.3% Verified
Orforglipron Cardinal Metabolic Clinic
Purity 98.2% Verified